(HealthDay)—Tamiflu (oseltamivir) can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.
Dec 22, 2012
2
0
There can be no debate about Tamiflu whilst Roche does not keep its promise to release "full study reports" about the drug, argue senior researchers from the Cochrane group today.
Nov 26, 2012
0
0
A leading British medical journal is asking the drug maker Roche to release all its data on Tamiflu, claiming there is no evidence the drug can actually stop the flu.
Nov 12, 2012
0
0
(Medical Xpress)—Children hospitalized for the flu are much less likely to require breathing support from a mechanical ventilator if they receive antiviral drugs like oseltamivir (Tamiflu) as soon as possible after admission, ...
Nov 8, 2012
0
0
In an open letter to company director, Professor Sir John Bell, she says: "Billions of pounds of public money have been spent on [Tamiflu] and yet the evidence on its effectiveness and safety remains hidden from appropriate ...
Oct 30, 2012
0
0
For the nearly 62 million Americans infected with influenza each year, oeseltamivir, commonly called Tamiflu, promises to offer relief. New research from the University of Georgia finds the medication may not have all of ...
Oct 26, 2012
1
0
(Medical Xpress)—In developed countries people over 65 years old are the most likely to die from an influenza outbreak and people in nursing homes, where the virus is difficult to control, are especially vulnerable.
Oct 18, 2012
0
0
Drug interactions and drug side effects occur all-too-often in patients' lives. Now there's a new online resource to help guide pharmaceutical developers as they endeavor to improve testing for potentially harmful drug interactions ...
Sep 5, 2012
0
0
The full clinical study reports of drugs that have been authorized for use in patients should be made publicly available in order to allow independent re-analysis of the benefits and risks of such drugs, according to leading ...
Apr 10, 2012
0
0
Two years after pharmaceutical giant Roche promised the BMJ it would release key Tamiflu trial data for independent scrutiny, the safety and effectiveness of this anti-influenza drug remains uncertain, warn experts today.
Jan 18, 2012
0
0
